Dr. Ueno is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
701 Ilalo Street, Room 622
Honolulu, HI 96813Phone+1 808-586-3013
Summary
- I am a board-certified internist and medical oncologist. I specialize in taking care of patients with inflammatory breast cancer, triple negative breast cancer, metastatic breast cancer, and bone metastasis. I have a passion to provide the best care to my patients.
Education & Training
- UT Graduate School of Biomedical SciencePhD, Cancer Biology, 1994 - 1999
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1993 - 1996
- UPMC Medical EducationResidency, Internal Medicine, 1990 - 1993
- OtherClass of 1989
Certifications & Licensure
- HI State Medical License 2022 - 2026
- TX State Medical License 1993 - 2026
- FL State Medical License 2021 - 2023
- OK State Medical License 2020 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regents’ Outstanding Teaching Award The University of Texas System, 2013
Clinical Trials
- Herceptin and GM-CSF for Metastatic Breast Cancer Start of enrollment: 2002 Aug 01
- Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer Start of enrollment: 2007 Apr 17
Roles: Contact, Principal Investigator
- Denosumab for Breast Cancer With Bone Mets Start of enrollment: 2015 Feb 09
- Join now to see all
Publications & Presentations
PubMed
- 1594 citationsPan-cancer analysis of whole genomesPeter J. Campbell, Gad Getz, Jan O. Korbel, Joshua M. Stuart, Jennifer L. Jennings
Nature. 2020-02-06 - 638 citationsGenome evolution in the allotetraploid frog Xenopus laevisAdam M. Session, Yoshinobu Uno, Taejoon Kwon, Jarrod Chapman, Atsushi Toyoda
Nature. 2016-10-20 - 63 citationsPoor response to neoadjuvant chemotherapy correlates with mast cell infiltration in inflammatory breast cancerSangeetha M. Reddy, Alexandre Reuben, Souptik Barua, Hong Jiang, Shaojun Zhang
Cancer Immunology Research. 2019-06-01
Journal Articles
- Rates of Immune Cell Infiltration in Patients with Triple-Negative Breast Cancer by Molecular SubtypeWendy A Woodward, Naoto T Ueno, Savitri Krishnamurthy, Bora Lim, PLoS One
- Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast CancerMichael C Stauder, Anthony Lucci, Wendy A Woodward, Bora Lim, Naoto T Ueno, ScienceDirect
Authored Content
- Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
- Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
- Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
- Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
- An Oncologist-Turned-Cancer-Patient’s Plea to ColleaguesMay 2018
- An Oncologist-Turned-Cancer-Patient’s Plea to ColleaguesMay 2018
- My Methodology: How I Treat Inflammatory Breast CancerApril 2018
- 5 Items Patients (And You) Should Complete to Prepare for the End of LifeJanuary 2018
- Prior Systemic Treatment Increased the Incidence of Somatic Mutations in Metastatic Breast CancerJanuary 2018
- Join now to see all
Press Mentions
- HER2-Low Breast Cancer: Despite New Data, Questions PersistOctober 24th, 2024
- Five Questions with Dr. Naoto Ueno, UH Cancer Center's New DirectorJanuary 30th, 2023
- MD Anderson Research Highlights for December 19, 2022December 19th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: